332 related articles for article (PubMed ID: 16029339)
1. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
2. TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.
Bäumer W; Seegers U; Braun M; Tschernig T; Kietzmann M
Br J Dermatol; 2004 Oct; 151(4):823-30. PubMed ID: 15491423
[TBL] [Abstract][Full Text] [Related]
3. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M
J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900
[TBL] [Abstract][Full Text] [Related]
4. Differential function of dendritic cells isolated from blood and lymph nodes.
Hill S; Coates JP; Kimber I; Knight SC
Immunology; 1994 Oct; 83(2):295-301. PubMed ID: 7835950
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Krekeler S; DeVries VC; Niedorf F; Tschernig T; Kietzmann M
Exp Dermatol; 2006 Apr; 15(4):322-9. PubMed ID: 16512880
[TBL] [Abstract][Full Text] [Related]
6. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Trautmann A; Akdis M; Schmid-Grendelmeier P; Disch R; Bröcker EB; Blaser K; Akdis CA
J Allergy Clin Immunol; 2001 Nov; 108(5):839-46. PubMed ID: 11692113
[TBL] [Abstract][Full Text] [Related]
7. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration.
Reines I; Kietzmann M; Mischke R; Tschernig T; Lüth A; Kleuser B; Bäumer W
J Invest Dermatol; 2009 Aug; 129(8):1954-62. PubMed ID: 19194476
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
Lappin MB; Dearman RJ; Norval M; Kimber I
Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
[TBL] [Abstract][Full Text] [Related]
9. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
Bhol KC; Schechter PJ
Br J Dermatol; 2005 Jun; 152(6):1235-42. PubMed ID: 15948987
[TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus and tacrolimus differ in their inhibition of lymphocyte activation during the sensitization phase of contact hypersensitivity.
Bavandi A; Fahrngruber H; Aschauer H; Hartmann B; Meingassner JG; Kalthoff FS
J Dermatol Sci; 2006 Aug; 43(2):117-26. PubMed ID: 16806841
[TBL] [Abstract][Full Text] [Related]
11. Effects of cilomilast on dendritic cell function in contact sensitivity and dendritic cell migration through skin.
Bäumer W; Tschernig T; Sülzle B; Seegers U; Lührmann A; Kietzmann M
Eur J Pharmacol; 2003 Nov; 481(2-3):271-9. PubMed ID: 14642795
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes.
Bäumer W; Kietzmann M
Vet Dermatol; 2007 Apr; 18(2):107-14. PubMed ID: 17355425
[TBL] [Abstract][Full Text] [Related]
13. Topical application of T-2 toxin inhibits the contact hypersensitivity response in BALB/c mice.
Blaylock BL; Kouchi Y; Comment CE; Pollock PL; Luster MI
J Immunol; 1993 Jun; 150(11):5135-43. PubMed ID: 8496607
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).
Panhans-Gross A; Novak N; Kraft S; Bieber T
J Allergy Clin Immunol; 2001 Feb; 107(2):345-52. PubMed ID: 11174203
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity.
Yamamoto A; Watanabe H; Sueki H; Nakanishi T; Yasuhara H; Iijima M
J Dermatol; 2007 Jul; 34(7):419-29. PubMed ID: 17584317
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus and TGF-beta act synergistically on the generation of Langerhans cells.
Kwiek B; Peng WM; Allam JP; Langner A; Bieber T; Novak N
J Allergy Clin Immunol; 2008 Jul; 122(1):126-32, 132.e1. PubMed ID: 18547634
[TBL] [Abstract][Full Text] [Related]
17. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
Shimizu T; Abe R; Nishihira J; Shibaki A; Watanabe H; Nakayama T; Taniguchi M; Ishibashi T; Shimizu H
Eur J Immunol; 2003 Jun; 33(6):1478-87. PubMed ID: 12778465
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of primary versus preactivated T cells by pimecrolimus but not by tacrolimus in vitro.
Kalthoff FS; Winiski A; Fichtinger P; Schwendinger B; Wang S; Weishaeupl C; Stuetz A
Int Arch Allergy Immunol; 2007; 142(3):255-64. PubMed ID: 17114891
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes.
Duperrier K; Velten FW; Bohlender J; Demory A; Metharom P; Goerdt S
Mol Immunol; 2005 Aug; 42(12):1531-40. PubMed ID: 15950746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
